GPCR Safety Panels Launched
October 15, 2024
We are pleased to introduce our new GPCR Safety Panels, designed to help evaluate the off-target potency of ca […]
Core Technology for Our GPCR Functional Assay Patented in Japan
November 8, 2023
We are pleased to announce that the core technology for our GPCR functional assay has been patented in Japan. […]
Panel Assay Service Launched
October 21, 2020
株式会社タンソーバイオサイエンス(本社:東京都文京区、代表取締役:小笠原英明、以下タンソー)は、ヒトGタンパク質共役型受容体(GPCR) 297種に対するパネルアッセイサービスを開始しました。業界最大規模の網羅的パネルアッセイに加え、カスタマイズ自在でお求めやすい48受容体パネル「FlexPanel48」を提供します。
Interview with Tanso Biosciences CEO by NIKKEI Biotech
March 16, 2020
At the interview by NIKKEI Biotech, CEO Hideaki Ogasawara talks about Tanso Biosciences' proprietary GPCR func […]
Distributor agreement with Cosmo Bio
March 10, 2020
Tanso Biosciences, Inc. has entered into a distributor agreement with Cosmo Bio Co., Ltd to provide contract a […]
GPCR ranking: Number of receptor-targeted drugs
December 6, 2019
All GPCRs are not made equal. As illustrated in "About GPCR," some GPCRs have dozens of drugs targeting them w […]